Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2010-2686

2. Registrant Information.

Registrant Reference Number: PROSAR 1-22241112

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.

13-APR-10

5. Location of incident.

Country: UNITED STATES

Prov / State: FLORIDA

6. Date incident was first observed.

12-APR-10

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No.       PMRA Submission No.       EPA Registration No. 2596-125

Product Name: UltraGuard Flea/Tick Spray for Dogs 16 fl oz

  • Active Ingredient(s)
    • TETRACHLORVINPHOS
      • Guarantee/concentration 1.08 %

7. b) Type of formulation.

Liquid

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The product was applied to four 6 week old kittens on 04/12/2010. NOTE: This product is not labeled for use on cats.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

No

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Shorthair

4. Number of animals affected

2

5. Sex

Unknown

6. Age (provide a range if necessary )

0.12

7. Weight (provide a range if necessary )

Unknown

8. Route(s) of exposure

Skin

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • General
    • Symptom - Death

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.

No

14. a) Was the animal hospitalized?

No

14. b) How long was the animal hospitalized?

15. Outcome of the incident

Died

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-22241112: A reporter (veterinarian) called on 04/13/2010 to report the exposure of four 6 week old kittens to a canine flea and tick spray containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to the kittens on 04/12/2010. At an unknown time following product application, 2 kittens were found dead (1st Subform III). The other 2 kittens became ill at an unknown time following product application with lethargy, depression, and anorexia and presented to the reporter. Kitten #1 (2nd Subform III) was unresponsive, hypothermic, and bradycardic at the time of the report. Kitten #2 (3rd Subform III) was severely depressed but responsive, hypothermic, and bradycardic at the time of the report. The reporter was advised that the spray does not contain alcohol but contains an organophosphate. The low dose atropine test method was discussed, as was the need for larger atropine doses of 0.25mg/kg in the treatment of organophosphate toxicity. The reporter was also advised to practice supportive care including warming and maintaining blood glucose. The company's cholinesterase testing policy was discussed. On follow up, the reporter stated that Kitten #1 and Kitten #2 were hospitalized for 2 days. Both kittens had improved significantly from the time of the initial report. No further information was obtained. NOTE: This product is not labeled for use on cats.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Death

19. Provide supplemental information here

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Shorthair

4. Number of animals affected

1

5. Sex

Unknown

6. Age (provide a range if necessary )

0.12

7. Weight (provide a range if necessary )

Unknown

8. Route(s) of exposure

Skin

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • General
    • Symptom - Lethargy
  • Nervous and Muscular Systems
    • Symptom - Depression
  • Gastrointestinal System
    • Symptom - Anorexia
  • General
    • Symptom - Hypothermia
  • Nervous and Muscular Systems
    • Symptom - Unresponsive
  • Cardiovascular System
    • Symptom - Bradycardia

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.

Yes

14. a) Was the animal hospitalized?

Yes

14. b) How long was the animal hospitalized?

2

Day(s) / Jour(s)

15. Outcome of the incident

Fully Recovered / Complètement rétabli

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-22241112: A reporter (veterinarian) called on 04/13/2010 to report the exposure of four 6 week old kittens to a canine flea and tick spray containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to the kittens on 04/12/2010. At an unknown time following product application, 2 kittens were found dead (1st Subform III). The other 2 kittens became ill at an unknown time following product application with lethargy, depression, and anorexia and presented to the reporter. Kitten #1 (2nd Subform III) was unresponsive, hypothermic, and bradycardic at the time of the report. Kitten #2 (3rd Subform III) was severely depressed but responsive, hypothermic, and bradycardic at the time of the report. The reporter was advised that the spray does not contain alcohol but contains an organophosphate. The low dose atropine test method was discussed, as was the need for larger atropine doses of 0.25mg/kg in the treatment of organophosphate toxicity. The reporter was also advised to practice supportive care including warming and maintaining blood glucose. The company's cholinesterase testing policy was discussed. On follow up, the reporter stated that Kitten #1 and Kitten #2 were hospitalized for 2 days. Both kittens had improved significantly from the time of the initial report. No further information was obtained. NOTE: This product is not labeled for use on cats.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Moderate

19. Provide supplemental information here

Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Shorthair

4. Number of animals affected

1

5. Sex

Unknown

6. Age (provide a range if necessary )

0.12

7. Weight (provide a range if necessary )

Unknown

8. Route(s) of exposure

Skin

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • General
    • Symptom - Lethargy
  • Nervous and Muscular Systems
    • Symptom - Depression
  • Gastrointestinal System
    • Symptom - Anorexia
  • General
    • Symptom - Hypothermia
  • Cardiovascular System
    • Symptom - Bradycardia

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.

Yes

14. a) Was the animal hospitalized?

Yes

14. b) How long was the animal hospitalized?

2

Day(s) / Jour(s)

15. Outcome of the incident

Fully Recovered / Complètement rétabli

16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-22241112: A reporter (veterinarian) called on 04/13/2010 to report the exposure of four 6 week old kittens to a canine flea and tick spray containing the active ingredient Tetrachlorvinphos. According to the reporter, the product was applied to the kittens on 04/12/2010. At an unknown time following product application, 2 kittens were found dead (1st Subform III). The other 2 kittens became ill at an unknown time following product application with lethargy, depression, and anorexia and presented to the reporter. Kitten #1 (2nd Subform III) was unresponsive, hypothermic, and bradycardic at the time of the report. Kitten #2 (3rd Subform III) was severely depressed but responsive, hypothermic, and bradycardic at the time of the report. The reporter was advised that the spray does not contain alcohol but contains an organophosphate. The low dose atropine test method was discussed, as was the need for larger atropine doses of 0.25mg/kg in the treatment of organophosphate toxicity. The reporter was also advised to practice supportive care including warming and maintaining blood glucose. The company's cholinesterase testing policy was discussed. On follow up, the reporter stated that Kitten #1 and Kitten #2 were hospitalized for 2 days. Both kittens had improved significantly from the time of the initial report. No further information was obtained. NOTE: This product is not labeled for use on cats.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Moderate

19. Provide supplemental information here